Evidence map›Paper›PMID 40606219›Full record

ArticleFrontiers in nephrology2025

Artificial intelligence in nephrology education: a multicenter survey of fellowship trainees at Mayo Clinic.

Mohammad S Sheikh, Charat Thongprayoon, Iasmina M Craici, Jing Miao, Fawad M Qureshi, Michael A Mao, Musab S Hommos, Mary Prendergast, Sumi Nair, Kianoush B Kashani and 1 more

Abstract read
In one paragraph

Article in Frontiers in nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohammad S SheikhDivision of Nephrology and Hypertension, Mayo Clinic Minnesota, Rochester, MN, United States.
Charat ThongprayoonDivision of Nephrology and Hypertension, Mayo Clinic Minnesota, Rochester, MN, United States.
Iasmina M CraiciDivision of Nephrology and Hypertension, Mayo Clinic Minnesota, Rochester, MN, United States.
Jing MiaoDivision of Nephrology and Hypertension, Mayo Clinic Minnesota, Rochester, MN, United States.
Fawad M QureshiDivision of Nephrology and Hypertension, Mayo Clinic Minnesota, Rochester, MN, United States.
Michael A MaoDivision of Nephrology and Hypertension, Mayo Clinic Florida, Jacksonville, FL, United States.
Musab S HommosDivision of Nephrology and Hypertension, Mayo Clinic Arizona, Phoenix, AZ, United States.
Mary PrendergastDivision of Nephrology and Hypertension, Mayo Clinic Florida, Jacksonville, FL, United States.
Sumi NairDivision of Nephrology and Hypertension, Mayo Clinic Arizona, Phoenix, AZ, United States.
Kianoush B KashaniDivision of Nephrology and Hypertension, Mayo Clinic Minnesota, Rochester, MN, United States.
Wisit CheungpasitpornDivision of Nephrology and Hypertension, Mayo Clinic Minnesota, Rochester, MN, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Artificial intelligence (AI) is increasingly recognized for its potential to enhance nephrology training and practice. However, the integration of AI into fellowship training remains inadequately explored. This study aimed to assess current AI utilization, perceptions, and educational needs among nephrology fellows at Mayo Clinic. Methods: A structured online survey was administered to 23 fellows-including those specializing in kidney transplantation and onco-nephrology-across three Mayo Clinic sites (Minnesota, Arizona, and Florida). The survey addressed domains such as current AI usage, perceived relevance of AI in clinical practice, interest in formal AI training, self-assessed comfort with AI integration, and barriers to adopting AI technologies in nephrology education. Results: A total of 21 fellows (91% response rate) participated in the survey. 76% of respondents rated AI as moderately to highly relevant to nephrology. Similarly, 76% indicated a moderate to very high interest in receiving targeted AI training. Despite these favorable perceptions, 76% had rarely or never used AI in their clinical or research activities, and none reported any formal AI education. Interactive workshops emerged as the preferred modality for AI training (52%), with limited knowledge cited as the primary barrier to adoption. Optimism was especially high regarding AI applications in predictive modeling (86%) and diagnostic imaging (81%), while confidence in AI for direct clinical decision-making remained cautious. Conclusion: There is significant interest among nephrology fellows in AI, along with a critical need for formal education and training. The enthusiasm for AI's potential contrasts with a cautious perspective towards its current use in clinical decision-making. Our study highlights the necessity for educational initiatives that bridge the knowledge gap and foster confidence in the appropriate use of AI technologies in Nephrology fellowship.

Indexed as

artificial intelligenceclinical decision-makingeducational needsfellowshipshealth knowledgenephrology fellowship

Identifiers

PMID40606219
PMCPMC12213394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.